How to Increase Adderall 5mg TID
Increase your Adderall dose by 2.5 to 5 mg per individual dose at weekly intervals until you achieve optimal symptom control or reach the maximum total daily dose of 40 mg. 1, 2
Dose Titration Protocol
Your current regimen is 5 mg three times daily (15 mg total daily dose), which leaves substantial room for upward titration. The FDA-approved dosing strategy for amphetamines follows this framework 2:
Weekly Increment Schedule
- Increase by 2.5-5 mg per dose (not per day) at weekly intervals 1
- For your TID schedule, this means you could increase to:
- Week 1: 7.5 mg TID (22.5 mg/day), or
- Week 1: 10 mg TID (30 mg/day)
- Continue weekly increases until symptoms are controlled
Maximum Dose Considerations
- FDA maximum: 40 mg total daily dose 2
- Expert consensus often limits to 40 mg/day for amphetamines 1
- Recent meta-analysis data suggests flexible titration to higher doses (when tolerated) improves both efficacy and acceptability 3
- Some clinical practice data supports exceeding 40 mg/day in select cases, though this requires careful monitoring 4
Critical Monitoring Requirements
Before and during dose increases, you must assess 1:
Cardiovascular screening:
- Blood pressure and pulse at each dose adjustment
- Adults should have BP/pulse checked quarterly 1
- Baseline cardiac history to exclude arrhythmias or structural heart disease
Symptom assessment:
- Weekly contact (phone acceptable) during titration 1
- Use standardized rating scales (ADHD Rating Scale or similar)
- Self-ratings are essential in adults 1
Side effect monitoring:
- Insomnia, decreased appetite, headaches, irritability 1
- Weight at each visit (appetite suppression is dose-related) 5
- Growth parameters if applicable
When to Stop Increasing
Stop titrating when you reach any of these endpoints:
- Optimal symptom control - Target ≥30% reduction in ADHD symptoms 3, 6
- Intolerable side effects - Most common are insomnia and appetite suppression 7, 8
- Maximum dose reached - 40 mg/day per FDA; some practitioners go higher with careful monitoring 4
- No additional benefit - If increasing dose yields no further improvement, more is not better 1
Important Clinical Nuances
The evidence strongly supports flexible-dose titration over fixed-dose approaches. A 2022 meta-analysis of 7,877 patients demonstrated that flexible titration (adjusting based on response and tolerability) maintains constant incremental benefits across the entire FDA-licensed dose range, while fixed-dose trials show diminishing returns above 20 mg amphetamine equivalents 3. This means you should continue increasing as long as you're experiencing additional benefit without dose-limiting side effects.
Common pitfall: Underdosing is frequent in clinical practice 3. Many patients benefit from doses higher than initially prescribed, and the incremental benefit of 30 mg versus 20 mg amphetamine can be substantial when individually titrated.
Duration of action consideration: Your TID immediate-release schedule provides coverage throughout the day. The typical dosing interval is 4-6 hours 2. If breakthrough symptoms occur between doses, this may indicate need for dose increase rather than more frequent dosing.
Alternative Strategy: Fixed-Dose Trial
You could alternatively use a systematic fixed-dose trial 1:
- Try different doses on a weekly basis (e.g., 7.5 mg TID, 10 mg TID, 12.5 mg TID)
- After 3-4 weeks, review which dose provided optimal benefit
- This ensures you don't miss a higher dose that might yield additional improvement
The key principle: titrate to clinical response and tolerability, not to an arbitrary dose target. 3